Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029127623> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3029127623 endingPage "366" @default.
- W3029127623 startingPage "361" @default.
- W3029127623 abstract "ObjectiveTo compare the efficacy of high flow nasal cannula oxygen therapy (HFNC) and non-invasive ventilation (NIV) in the treatment of chronic obstructive pulmonary disease (COPD) with acute-moderate typeⅡ respiratory failure, and to explore the feasibility of HFNC in the treatment of COPD with respiratory failure.MethodsPatients diagnosed with COPD with acute moderate typeⅡ respiratory failure (Arterial blood gas pH 7.25-7.35, PaCO2> 50 mmHg) admitted to the ICUs from April 2017 to December 2017 were retrospectively analyzed. All patients who were treated with HFNC within the first 4 hours after the admission to the ICUs, and continued for more than 2 hours and for at least 4 hours within the first 24 hours were included in the HFNC group. Those treated with NIV in the same conditions were included in the NIV group. The end point was the failure rates of treatment (changing to respiratory support method in another group or invasive ventilation) and 28-day mortality.ResultsEighty-two patients (39 in the HFNC group and 43 in the NIV group) were enrolled. The HFNC group had a treatment failure rate of 28.2%, which was lower than that of the NIV group (39.5%). However, Kaplan-Meier curve analysis showed no significant difference between the two groups (Log Rank test 1.228, P=0.268). The 28-day mortality rate in HFNC group was 15.4%, which was no different from 14% in NIV group (Log Rank test 0.049, P=0.824). The number of airway care interventions within the first 24 hours was significantly lower in the HFNC group than in the NIV group [5 (3~8) vs. 11 (7~15)], whereas the duration of respiratory support within the first 24 hours was significantly longer in the HFNC group than in the NIV group [16 (9~22) hours vs. 8 (4~11) hours] (all P<0.05). The incidence of nasal facial lesions in the NIV group was 20.9%, significantly higher than that of HFNC group (5.1%, P <0.05).ConclusionFor COPD with acute moderate typeⅡ respiratory failure, HFNC has similar therapeutic effects as NIV. HFNC has better therapeutic tolerance and is a new potential respiratory support method for clinical treatment of COPD with respiratory failure.Key words: Chronic obstructive pulmonary diseases; Respiratory failure; High-flow nasal cannula oxygen therapy; Non-invasive ventilation; Cohort study" @default.
- W3029127623 created "2020-06-05" @default.
- W3029127623 creator A5002974065 @default.
- W3029127623 creator A5020389543 @default.
- W3029127623 creator A5022620574 @default.
- W3029127623 creator A5031675994 @default.
- W3029127623 creator A5047932356 @default.
- W3029127623 creator A5077251841 @default.
- W3029127623 creator A5089216875 @default.
- W3029127623 date "2018-04-10" @default.
- W3029127623 modified "2023-09-23" @default.
- W3029127623 title "High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary diseases with acute-moderate hypercapnic respiratory failure: an observational cohort study" @default.
- W3029127623 doi "https://doi.org/10.3760/cma.j.issn.1671-0282.2018.04.005" @default.
- W3029127623 hasPublicationYear "2018" @default.
- W3029127623 type Work @default.
- W3029127623 sameAs 3029127623 @default.
- W3029127623 citedByCount "0" @default.
- W3029127623 crossrefType "journal-article" @default.
- W3029127623 hasAuthorship W3029127623A5002974065 @default.
- W3029127623 hasAuthorship W3029127623A5020389543 @default.
- W3029127623 hasAuthorship W3029127623A5022620574 @default.
- W3029127623 hasAuthorship W3029127623A5031675994 @default.
- W3029127623 hasAuthorship W3029127623A5047932356 @default.
- W3029127623 hasAuthorship W3029127623A5077251841 @default.
- W3029127623 hasAuthorship W3029127623A5089216875 @default.
- W3029127623 hasConcept C126322002 @default.
- W3029127623 hasConcept C127413603 @default.
- W3029127623 hasConcept C141071460 @default.
- W3029127623 hasConcept C200457457 @default.
- W3029127623 hasConcept C2776780178 @default.
- W3029127623 hasConcept C2776888751 @default.
- W3029127623 hasConcept C2777953023 @default.
- W3029127623 hasConcept C2778074680 @default.
- W3029127623 hasConcept C2780334268 @default.
- W3029127623 hasConcept C2780630273 @default.
- W3029127623 hasConcept C42219234 @default.
- W3029127623 hasConcept C71924100 @default.
- W3029127623 hasConcept C78519656 @default.
- W3029127623 hasConcept C8213797 @default.
- W3029127623 hasConcept C84393581 @default.
- W3029127623 hasConceptScore W3029127623C126322002 @default.
- W3029127623 hasConceptScore W3029127623C127413603 @default.
- W3029127623 hasConceptScore W3029127623C141071460 @default.
- W3029127623 hasConceptScore W3029127623C200457457 @default.
- W3029127623 hasConceptScore W3029127623C2776780178 @default.
- W3029127623 hasConceptScore W3029127623C2776888751 @default.
- W3029127623 hasConceptScore W3029127623C2777953023 @default.
- W3029127623 hasConceptScore W3029127623C2778074680 @default.
- W3029127623 hasConceptScore W3029127623C2780334268 @default.
- W3029127623 hasConceptScore W3029127623C2780630273 @default.
- W3029127623 hasConceptScore W3029127623C42219234 @default.
- W3029127623 hasConceptScore W3029127623C71924100 @default.
- W3029127623 hasConceptScore W3029127623C78519656 @default.
- W3029127623 hasConceptScore W3029127623C8213797 @default.
- W3029127623 hasConceptScore W3029127623C84393581 @default.
- W3029127623 hasIssue "4" @default.
- W3029127623 hasLocation W30291276231 @default.
- W3029127623 hasOpenAccess W3029127623 @default.
- W3029127623 hasPrimaryLocation W30291276231 @default.
- W3029127623 hasRelatedWork W2159822959 @default.
- W3029127623 hasRelatedWork W2173944549 @default.
- W3029127623 hasRelatedWork W2552097681 @default.
- W3029127623 hasRelatedWork W2736373257 @default.
- W3029127623 hasRelatedWork W2747438374 @default.
- W3029127623 hasRelatedWork W2781319297 @default.
- W3029127623 hasRelatedWork W2794410306 @default.
- W3029127623 hasRelatedWork W2802444054 @default.
- W3029127623 hasRelatedWork W2909349320 @default.
- W3029127623 hasRelatedWork W2919138282 @default.
- W3029127623 hasRelatedWork W2977037358 @default.
- W3029127623 hasRelatedWork W2989596038 @default.
- W3029127623 hasRelatedWork W2991225181 @default.
- W3029127623 hasRelatedWork W3016390580 @default.
- W3029127623 hasRelatedWork W3029585698 @default.
- W3029127623 hasRelatedWork W3030153948 @default.
- W3029127623 hasRelatedWork W3037626609 @default.
- W3029127623 hasRelatedWork W3047301060 @default.
- W3029127623 hasRelatedWork W3107242054 @default.
- W3029127623 hasRelatedWork W3204962267 @default.
- W3029127623 hasVolume "27" @default.
- W3029127623 isParatext "false" @default.
- W3029127623 isRetracted "false" @default.
- W3029127623 magId "3029127623" @default.
- W3029127623 workType "article" @default.